Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1980 Oct;33(10):973–976. doi: 10.1136/jcp.33.10.973

Determination of plasma malondialdehyde-like material and its clinical application in stroke patients.

M T Santos, J Valles, J Aznar, J Vilches
PMCID: PMC1146297  PMID: 7430363

Abstract

Plasma malondialdehyde-like material (MDA-LM) was evaluated in 138 normal subjects and in a group of 57 stroke patients using a modification of the method of Smith et al. (1976). The basal level of MDA-LM in the control group was 35 mumol/l with a range of 22-50 mumol/l. Values above 50 mumol/l were found in 80% of the patients suffering from subarachnoid haemorrhage, in 68% of those with cerebral thrombosis, and in 17% with transient ischaemic attacks. None of the patients with cerebral embolism, intracerebral haematoma, or lacunar infarct had values above 50 mumol/l. Significant statistical differences were found between the control group and all the patients except those with lacunar infarcts.

Full text

PDF
973

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bills T. K., Smith J. B., Silver M. J. Metabolism of [14C]arachidonic acid by human platelets. Biochim Biophys Acta. 1976 Feb 23;424(2):303–314. doi: 10.1016/0005-2760(76)90198-3. [DOI] [PubMed] [Google Scholar]
  2. Bolton A. E., Ludlam C. A., Moore S., Pepper D. S., Cash J. D. Three approaches to the radioimmunoassay of human beta-thromboglobulin. Br J Haematol. 1976 Jun;33(2):233–238. doi: 10.1111/j.1365-2141.1976.tb03534.x. [DOI] [PubMed] [Google Scholar]
  3. Boudouresques G., Hauw J. J., Escourolle R., Pertuiset B., Buge A., Lhermitte F., Castaigne P. Diagnostic des hémorragies cérébrales. 247 observations anatomiques. Nouv Presse Med. 1979 Apr 21;8(18):1479–1482. [PubMed] [Google Scholar]
  4. Bragt P. C., Schenkelaars E. P., Bonta I. L. Dissociation between prostaglandin and malondialdehyde formation in exudate and increased levels of malondialdehyde in plasma and liver during granulomatous inflammation in the rat. Prostaglandins Med. 1979 Jan;2(1):51–61. doi: 10.1016/s0161-4630(79)80008-7. [DOI] [PubMed] [Google Scholar]
  5. Giardini O., Murgia F., Martino F., Mannarino O., Corrado G., Maggioni G. Serum lipid pattern in beta-thalassaemia. Acta Haematol. 1978;60(2):100–107. doi: 10.1159/000207703. [DOI] [PubMed] [Google Scholar]
  6. Hamberg M., Svensson J., Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A. 1975 Aug;72(8):2994–2998. doi: 10.1073/pnas.72.8.2994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kaplan K. L., Nossel H. L., Drillings M., Lesznik G. Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation. Br J Haematol. 1978 May;39(1):129–146. doi: 10.1111/j.1365-2141.1978.tb07135.x. [DOI] [PubMed] [Google Scholar]
  8. MacFarlane D. E., Gardner S., Lipson C., Mills D. C. Malondialdehyde production by platelets during secondary aggregation. Thromb Haemost. 1977 Dec 15;38(4):1002–1009. [PubMed] [Google Scholar]
  9. Mohr J. P., Caplan L. R., Melski J. W., Goldstein R. J., Duncan G. W., Kistler J. P., Pessin M. S., Bleich H. L. The Harvard Cooperative Stroke Registry: a prospective registry. Neurology. 1978 Aug;28(8):754–762. doi: 10.1212/wnl.28.8.754. [DOI] [PubMed] [Google Scholar]
  10. Moncada S., Vane J. R. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med. 1979 May 17;300(20):1142–1147. doi: 10.1056/NEJM197905173002006. [DOI] [PubMed] [Google Scholar]
  11. Muus P., Bonta I. L., den Oudsten S. A. Plasma levels of malondialdehyde, a product of cyclo-oxygenase-dependent and independent lipid peroxidation in rheumatoid arthritis: a correlation with disease activity. Prostaglandins Med. 1979 Jan;2(1):63–65. doi: 10.1016/s0161-4630(79)80009-9. [DOI] [PubMed] [Google Scholar]
  12. Nossel H. L., Ti M., Kaplan K. L., Spanondis K., Soland T., Butler V. P., Jr The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity. J Clin Invest. 1976 Nov;58(5):1136–1144. doi: 10.1172/JCI108566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. O'Brien J. R., Etherington M., Jamieson S., Lawford P. Letter: Heparin thrombin clotting-time and platelet factor 4. Lancet. 1974 Sep 14;2(7881):656–657. doi: 10.1016/s0140-6736(74)91982-5. [DOI] [PubMed] [Google Scholar]
  14. Plaa G. L., Witschi H. Chemicals, drugs, and lipid peroxidation. Annu Rev Pharmacol Toxicol. 1976;16:125–141. doi: 10.1146/annurev.pa.16.040176.001013. [DOI] [PubMed] [Google Scholar]
  15. Pryor W. A., Stanley J. P. Letter: A suggested mechanism for the production of malonaldehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation. J Org Chem. 1975 Nov 28;40(24):3615–3617. doi: 10.1021/jo00912a038. [DOI] [PubMed] [Google Scholar]
  16. Robak J., Sobańska B. Relationship between lipid peroxidation and prostaglandin generation in rabbit tissues. Biochem Pharmacol. 1976 Oct 15;25(20):2233–2236. doi: 10.1016/0006-2952(76)90002-2. [DOI] [PubMed] [Google Scholar]
  17. Santos M. T., Aznar J., Valles J., Fernandez M. A. The determination of MDA as a simple technique for the control of the therapy with aspirin. Thromb Res. 1979 Feb-Mar;14(2-3):513–518. doi: 10.1016/0049-3848(79)90260-3. [DOI] [PubMed] [Google Scholar]
  18. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta. 1978 Nov 15;90(1):37–43. doi: 10.1016/0009-8981(78)90081-5. [DOI] [PubMed] [Google Scholar]
  19. Sixma J. J. Techniques for diagnosing prethrombotic states: a review. Thromb Haemost. 1978 Oct 31;40(2):252–259. [PubMed] [Google Scholar]
  20. Smith J. B., Ingerman C. M., Silver M. J. Malondialdehyde formation as an indicator of prostaglandin production by human platelets. J Lab Clin Med. 1976 Jul;88(1):167–172. [PubMed] [Google Scholar]
  21. Stuart M. J., Murphy S., Oski F. A. A simple nonradioisotope technic for the determination of platelet life-span. N Engl J Med. 1975 Jun 19;292(25):1310–1313. doi: 10.1056/NEJM197506192922502. [DOI] [PubMed] [Google Scholar]
  22. Tappel A. L. Lipid peroxidation damage to cell components. Fed Proc. 1973 Aug;32(8):1870–1874. [PubMed] [Google Scholar]
  23. Tomita I., Sano M., Serizawa S., Ohta K., Katou M. Fluctuation of lipid peroxides and related enzyme activities at time of stroke in stroke-prone spontaneously hypertensive rats. Stroke. 1979 May-Jun;10(3):323–326. doi: 10.1161/01.str.10.3.323. [DOI] [PubMed] [Google Scholar]
  24. Zucker M. B. Proquazone (Sandoz 43-715), an unusually potent inhibitor of the platelet release reaction and malondialdehyde formation. Proc Soc Exp Biol Med. 1977 Nov;156(2):209–212. doi: 10.3181/00379727-156-39908. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES